232 related articles for article (PubMed ID: 7809028)
1. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.
Whitlow M; Filpula D; Rollence ML; Feng SL; Wood JF
Protein Eng; 1994 Aug; 7(8):1017-26. PubMed ID: 7809028
[TBL] [Abstract][Full Text] [Related]
2. Crystallization of single-chain Fv proteins.
Essig NZ; Wood JF; Howard AJ; Raag R; Whitlow M
J Mol Biol; 1993 Dec; 234(3):897-901. PubMed ID: 8254684
[TBL] [Abstract][Full Text] [Related]
3. Single-chain Fvs.
Raag R; Whitlow M
FASEB J; 1995 Jan; 9(1):73-80. PubMed ID: 7821762
[TBL] [Abstract][Full Text] [Related]
4. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
5. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3.
Desplancq D; King DJ; Lawson AD; Mountain A
Protein Eng; 1994 Aug; 7(8):1027-33. PubMed ID: 7809029
[TBL] [Abstract][Full Text] [Related]
6. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
7. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability.
Whitlow M; Bell BA; Feng SL; Filpula D; Hardman KD; Hubert SL; Rollence ML; Wood JF; Schott ME; Milenic DE
Protein Eng; 1993 Nov; 6(8):989-95. PubMed ID: 8309948
[TBL] [Abstract][Full Text] [Related]
8. Properties of bispecific single chain antibodies expressed in Escherichia coli.
Kranz DM; Gruber M; Wilson ER
J Hematother; 1995 Oct; 4(5):403-8. PubMed ID: 8581376
[TBL] [Abstract][Full Text] [Related]
9. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
[TBL] [Abstract][Full Text] [Related]
10. Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system.
Asano R; Takemura S; Tsumoto K; Sakurai N; Teramae A; Ebara S; Katayose Y; Shinoda M; Suzuki M; Imai K; Matsuno S; Kudo T; Kumagai I
J Biochem; 2000 Apr; 127(4):673-9. PubMed ID: 10739961
[TBL] [Abstract][Full Text] [Related]
11. Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen.
Tsumoto K; Nishimiya Y; Kasai N; Ueda H; Nagamune T; Ogasahara K; Yutani K; Tokuhisa K; Matsushima M; Kumagai I
Protein Eng; 1997 Nov; 10(11):1311-8. PubMed ID: 9514120
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the octapeptide angiotensin II with a high-affinity single-chain Fv and with peptides derived from the antibody paratope.
Cohen P; Laune D; Teulon I; Combes T; Pugnière M; Badouaille G; Granier C; Mani JC; Simon D
J Immunol Methods; 2001 Aug; 254(1-2):147-60. PubMed ID: 11406160
[TBL] [Abstract][Full Text] [Related]
13. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: recovery of active FV fragments.
Cheadle C; Hook LE; Givol D; Ricca GA
Mol Immunol; 1992 Jan; 29(1):21-30. PubMed ID: 1731188
[TBL] [Abstract][Full Text] [Related]
15. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
16. A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: comparison with its single-chain and disulfide-stabilized homologs.
Rajagopal V; Pastan I; Kreitman RJ
Protein Eng; 1997 Dec; 10(12):1453-9. PubMed ID: 9543007
[TBL] [Abstract][Full Text] [Related]
17. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand.
Mallender WD; Carrero J; Voss EW
J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386
[TBL] [Abstract][Full Text] [Related]
18. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.
Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I
Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039
[TBL] [Abstract][Full Text] [Related]
19. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
[TBL] [Abstract][Full Text] [Related]
20. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Wittel UA; Batra SK
Int J Cancer; 2001 Dec; 94(5):717-26. PubMed ID: 11745468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
